Zhejiang Taimei Medical Technology Co. Ltd. Announces CSRC Filing for Full Circulation of H Shares, Initiating Regulatory Review for Share Conversion and Hong Kong Listing

**Zhejiang Taimei Medical Technology Co. Ltd. Announces Progress in H Share Full Circulation Regulatory Review** Zhejiang Taimei Medical Technology Co. Ltd. (HKEX: 2576) has announced that it has submitted a filing to the China Securities Regulatory Commission (CSRC) regarding the proposed implementation of the full circulation of its H shares. The company is seeking regulatory approval to convert 363,186,467 domestic shares into H shares, which will then be listed on the Hong Kong Stock Exchange. The conversion and listing are subject to approval and the completion of required procedures by the CSRC, the Hong Kong Stock Exchange, and other relevant authorities. Zhejiang Taimei Medical Technology Co. Ltd. is currently undergoing regulatory review and will provide further updates as appropriate. No grant or funding has been announced in connection with this regulatory process, and the application pertains solely to Zhejiang Taimei Medical Technology Co. Ltd.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zhejiang Taimei Medical Technology Co. Ltd. published the original content used to generate this news brief on September 29, 2025, and is solely responsible for the information contained therein.